View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
August 10, 2022

Gerresheimer to invest to expand vial production capacity in US

The company will add advanced forming lines to its facility in North Carolina to increase its annual production capacity.

German pharmaceutical packaging supplier Gerresheimer has announced an investment of up to $94m to increase its manufacturing, supply and logistics capability for glass vials in the US.

As part of the expansion project, the company will add vial forming lines to its facility in Morganton, North Carolina.

These will include dimensional inspection, annealing, cosmetic inspection and packaging lines.

In addition, the company will develop a warehouse at the facility.

The project is backed by the US Biomedical Advanced Research and Development Authority (BARDA) through a 70/30 cost-share cooperative agreement.

The authority, which is part of the Office of the Assistant Secretary for Preparedness and Response (ASPR), has agreed to provide up to approximately $66m to Gerresheimer for the project.

Under the agreement, Gerresheimer will increase the Morganton facility’s annual production capacity by adding interchangeable Type 1 vial (glass borosilicate and/or aluminosilicate) and Gx Elite Glass Vial capabilities.

The vials will be used in vaccination campaigns against Covid-19 and other infectious diseases.

The investment is in line with Gerresheimer’s expansion strategy and follows its strategy process formula G.

It is also intended to strengthen the company’s position as an ‘elite’ vial provider and create job opportunities at the facility.

Gerresheimer CEO Dietmar Siemssen said: “Gerresheimer is honoured to support the US Government in strengthening its pharmaceutical supply chain for current and future healthcare emergencies.

“The agreement confirms our role as a supplier of system critical products, such as pharmaceutical primary packaging solutions and drug delivery systems for the healthcare sector.

“This investment follows our strategy process formula G and accelerates our growth in this important market.”

Based in Düsseldorf, Gerresheimer supplies packaging and products for the pharmaceutical and healthcare industries.

Last month, the company reported a 13% increase in organic revenue to €445m in the second quarter (Q2) of the fiscal year 2022 (FY22).

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The packaging industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Packaging Gateway